You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic granulocytic leukemia (CGL)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Copd Trial in Cairo (Nebivolol Tablets)

Recruiting
  • Copd
  • Nebivolol Tablets
  • Cairo, Egypt
  • +2 more
Apr 10, 2021

Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

Exercise Training, Physical Activity Trial in Gent (Lactose, Fexofenadine Hydrochloride, Famotidine)

Completed
  • Exercise Training
  • Physical Activity
  • Lactose
  • +3 more
  • Gent, Oost-Vlaanderen, Belgium
    Department of Movement and Sports Sciences, Ghent University
Jul 29, 2021

People With Long-term Type 1 Diabetes

Recruiting
  • Type 1 Diabetes
  • Chronic hyperglycemia
  • +6 more
  • Changsha, Hu Nan, China
    Institute of Metabolism and Endocrinology, Second Xiangya Hospit
Apr 28, 2022

Lung Disease Chronic Trial in Toronto (exoskeleton assist)

Completed
  • Lung Disease Chronic
  • exoskeleton assist
  • Toronto, Ontario, Canada
    Westpark Health Care Centre
Apr 27, 2022

Myocardial Infarction Trial in Portugal, Spain (AGTP-treatment, Control)

Recruiting
  • Myocardial Infarction
  • AGTP-treatment
  • Control
  • Porto, Portugal
  • +11 more
Sep 6, 2021

Chronic Total Occlusion of Coronary Artery Trial in Amsterdam (Percutaneous coronary intervention (PCI))

Recruiting
  • Chronic Total Occlusion of Coronary Artery
  • Percutaneous coronary intervention (PCI)
  • Amsterdam, Netherlands
    Amsterdam UMC, location AMC
Feb 14, 2022

Cardiogenic Shock Trial in Philadelphia (Impella-CP LV Vent)

Active, not recruiting
  • Cardiogenic Shock
  • Impella-CP LV Vent
  • Philadelphia, Pennsylvania
    Hospital of The University of Pennsylvania
Nov 4, 2022

COPD Trial in United States (YPL-001 80 mg, YPL-001 160 mg, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • YPL-001 80 mg
  • +2 more
  • Birmingham, Alabama
  • +3 more
Jun 24, 2021

Objective Data on Daily Activity in Patients Treated With SCS:

Recruiting
  • Failed Back Surgery Syndrome
  • Spinal cord stimulation
  • Roeselare, Belgium
  • +6 more
Sep 20, 2021

Systemic Lupus Erythematosus Trial in Shanghai (Belimumab, Placebo)

Recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • Placebo
  • Shanghai, Shanghai, China
    Shuang Ye, MD
Sep 27, 2021

Anemia, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Ho Chi Minh City (Stimus (NNG-DEPO))

Active, not recruiting
  • Anemia
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Stimus (NNG-DEPO)
  • Ho Chi Minh City, Vietnam
    NANOGEN Pharmaceutical Biotechnology JSC
Jan 4, 2023

COVID-19 Trial in Seattle (Rehabilitation-focused program)

Recruiting
  • COVID-19
  • Rehabilitation-focused program
  • Seattle, Washington
    VA Puget Sound Health Care System Seattle Division, Seattle, WA
Dec 2, 2021

Chronic Stroke, Subacute Stroke Trial in Bad Pirawarth (Cerebrolysin, non-invasive brain stimulation, Placebo)

Terminated
  • Chronic Stroke
  • Subacute Stroke
  • Bad Pirawarth, Austria
    Klinik Pirawarth
Jul 26, 2022

Emphysema Trial in Palo Alto (Stereotactic Ablative Radiotherapy (SABR))

Recruiting
  • Emphysema
  • Stereotactic Ablative Radiotherapy (SABR)
  • Palo Alto, California
    Stanford Cancer Center
Oct 24, 2022

Kidney Injury, Acute, Cardiac Function Failed Trial in Santiago (Vasopressor test)

Recruiting
  • Kidney Injury, Acute
  • Cardiac Function Failed
  • Vasopressor test
  • Santiago, Metropolitana, Chile
    Hospital Clínico Pontificia Universidad Católica de Chile
Nov 6, 2023

Early Screener to Identify Long-term Problems With Regard to

Completed
  • Type 1 Diabetes
    • Zürich, Switzerland
      University Children's Hospital Zurich
    Apr 20, 2022

    SARS-Cov-2 Induced Pulmonary Fibrosis Trial in Paris (Nintedanib 150 MG [Ofev], Placebo)

    Recruiting
    • SARS-Cov-2 Induced Pulmonary Fibrosis
    • Nintedanib 150 MG [Ofev]
    • Placebo
    • Paris, France
      Pneumologie
    May 2, 2022

    Schizophrenia Trial in Aizuwakamatsu (MP-214, Risperidone)

    Completed
    Has Results
    • Schizophrenia
    • Aizuwakamatsu, Fukushima, Japan
      (unnamed)
    Apr 8, 2021

    Chronic Disease Trial in Marseille (Quality of life questionnaire)

    Unknown status
    • Chronic Disease
    • Quality of life questionnaire
    • Marseille, France
      Assistance Publique Hopitaux de Marseille
    Jan 27, 2021

    End Stage Renal Disease Trial in Durham (UFR-restricted dialysis, UFR-unrestricted dialysis)

    Withdrawn
    • End Stage Renal Disease
    • UFR-restricted dialysis
    • UFR-unrestricted dialysis
    • Durham, North Carolina
      Duke University Medical Center
    Jul 15, 2021

    Prolonged Pain, EEG, Resting State Functional Connectivity Trial in Aalborg (8% Capsaicin patch, patch)

    Completed
    • Prolonged Pain, EEG, Resting State Functional Connectivity
    • 8% Capsaicin patch
    • placebo patch
    • Aalborg, Denmark
      Aalborg University, Department of Health Sciences and technology
    Mar 10, 2022

    Breast Diseases, Mastitis Granulomatous, Psychiatric Disorder Trial in Wuhan (conservative treatment)

    Enrolling by invitation
    • Breast Diseases
    • +2 more
    • conservative treatment
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    May 24, 2022

    STOP CSUA: phySical acTivity, mOod and sleeP in Chronic

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • Physical activity monitoring - Symptom monitoring
    • Dublin, Ireland
      St. James's Hospital
    Dec 13, 2021

    HIV, Depression, Pain Trial in Boston, Minneapolis, Providence (HIVPASS, Health Education)

    Completed
    • HIV
    • +2 more
    • HIVPASS
    • Health Education
    • Boston, Massachusetts
    • +3 more
    Jun 8, 2021